You are here

Glaxo may consider spinoffs after Novartis deal is completed

gsk.jpg
GlaxoSmithKline Plc chief executive officer Andrew Witty is willing to consider suggestions made by investors to break up the company - although it may not happen for at least a year or two.

London

GLAXOSMITHKLINE Plc chief executive officer Andrew Witty is willing to consider suggestions made by investors to break up the company - although it may not happen for at least a year or two.

A deal with Novartis AG that closed in March created market-leading businesses in

sentifi.com

Market voices on:

grab

Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at btsub.sg/promo

Powered by GET.comGetCom